Signalling scaffolds and adaptors in T-cell immunity

GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

Signal transduction and targeted therapy·2026

CD4/CD8-p56lck Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy.

Biomolecules·2025

GSK-3 regulates CD4-CD8 cooperation needed to generate super-armed CD8+ cytolytic T cells against tumors.

bioRxiv : the preprint server for biology·2025

The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.

Communications biology·2025

Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy.

bioRxiv : the preprint server for biology·2024

PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity.

Cell reports·2024

Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

British journal of haematology·2026

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

British journal of haematology·2026

CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

British journal of haematology·2026

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

British journal of haematology·2026

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

British journal of haematology·2026

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

British journal of haematology·2026

A multitargeting nanoparticle-based vaccine for enhanced anticancer immunotherapy in HER2-Positive breast cancer.

Materials today. Bio·2026

Ferritin heavy chain 1 expression is correlated with plasma cell exhaustion and acts as a prognostic correlative marker in hepatocellular carcinoma.

Frontiers in immunology·2026

Bladder mucosal apoptosis index and quality of life after adjuvant intravesical BCG therapy for non-muscle-invasive bladder cancer: a retrospective propensity-score-matched study.

Frontiers in oncology·2026

Chemotherapy-induced myasthenia gravis presenting as isolated bulbar palsy in a patient with WHO type B3 thymoma: A case report.

Medicine·2026

Tick-borne tularaemia as a differential diagnosis in ulcerative skin infection and regional lymphadenopathy in children: a case report.

Journal of medical case reports·2026

Pancreatic tuberculosis: Likely originating from peripancreatic tuberculous lymphadenitis.

Hepatobiliary & pancreatic diseases international : HBPD INT·2026

Related Experiment Videos

Signalling scaffolds and adaptors in T-cell immunity

Related Concept Videos

GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

CD4/CD8-p56lck Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy.

GSK-3 regulates CD4-CD8 cooperation needed to generate super-armed CD8+ cytolytic T cells against tumors.

The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.

Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy.

PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity.

Pathway alteration burden derived from whole-exome sequencing is associated with survival in primary central nervous system lymphoma.

Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

CD47 promotes myeloma cell growth through JAK-STAT3/MYC signalling and is targetable by ruxolitinib.

The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Multiparameter flow cytometry versus droplet digital polymerase chain reaction for monitoring measurable residual disease in paediatric fusion gene-positive acute myeloid leukaemia.

A multitargeting nanoparticle-based vaccine for enhanced anticancer immunotherapy in HER2-Positive breast cancer.

Ferritin heavy chain 1 expression is correlated with plasma cell exhaustion and acts as a prognostic correlative marker in hepatocellular carcinoma.

Bladder mucosal apoptosis index and quality of life after adjuvant intravesical BCG therapy for non-muscle-invasive bladder cancer: a retrospective propensity-score-matched study.

Chemotherapy-induced myasthenia gravis presenting as isolated bulbar palsy in a patient with WHO type B3 thymoma: A case report.

Tick-borne tularaemia as a differential diagnosis in ulcerative skin infection and regional lymphadenopathy in children: a case report.

Pancreatic tuberculosis: Likely originating from peripancreatic tuberculous lymphadenitis.

Related Experiment Videos

Signalling scaffolds and adaptors in T-cell immunity

Related Concept Videos

Related Articles